In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease.
about
[13C]aminopyrine and [13C]caffeine breath test: influence of gender, cigarette smoking and oral contraceptives intake.The clinical importance of conventional and quantitative liver function tests in liver transplantation.Review article: breath testing for human liver function assessment.How useful is the "cocktail approach" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo?Clinical pathology approaches to hepatic injury.Consequences of renal failure on non-renal clearance of drugs.Rapid stimulation of free glucuronate formation by non-glucuronidable xenobiotics in isolated rat hepatocytes.Measurement of hepatic and intestinal CYP3A4 and PGP activity by combined po + iv [14C]erythromycin breath and urine test.CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus.Docetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C14-erythromycin breath test and the antipyrine clearance testAssessment of liver function in chickens using galactose and indocyanine green clearances
P2860
Q33961262-D2B72A3C-0FFE-4DB9-9412-A46DF947CC04Q34109294-E185AF0B-4C01-45AB-9A3E-CFACF55E3AF5Q35009519-A1157D2F-5DAC-43F4-AAC5-C995BB9F1889Q35149421-2763F40F-EE88-4CBF-8835-2D6CE572CA67Q36086403-BD9EEDC3-F3C9-4EAB-B5EE-BA65B0273733Q38214827-9249630D-AE90-4223-8EE2-AB55D533266BQ44514682-D1BE7D2C-A728-4858-9CD8-D1F3F3A9D9ABQ44543753-CD8BBD63-15B5-45DF-8ABD-7302E5986863Q45016045-CCFBA757-5742-46BE-96D4-32A15DBADCCFQ57265718-B67F00B8-A4DE-40EC-BBB9-497FE22A953CQ57626122-572DE209-795F-443D-B946-28FFC0948D20
P2860
In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease.
@en
type
label
In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease.
@en
prefLabel
In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease.
@en
P1476
In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease.
@en
P2093
P304
P356
10.1046/J.1365-2710.1997.10875108.X
P577
1997-08-01T00:00:00Z